Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2025-09-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DMSO
dimethyl sulfoxide
dentin pretreated using dimethyl sulfoxide and follow up of patients at 2 weeks, 3 months and 6 months
CHX
Cholorhexidine
dentin pretreated using chlorhexidine and follow up of patients at 2 weeks, 3months and 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dimethyl sulfoxide
dentin pretreated using dimethyl sulfoxide and follow up of patients at 2 weeks, 3 months and 6 months
Cholorhexidine
dentin pretreated using chlorhexidine and follow up of patients at 2 weeks, 3months and 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of patient: 50 - 75 years
* Patients with non caries cervical lesion will be standardized by clinical performance (FDI world dental federation).
Exclusion Criteria
* Developmental disorders and adjacent soft tissue lesions
* Patients with systemic illness will be excluded.
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aisha Nasr Ali Zahran
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aisha Zahran
Role: STUDY_DIRECTOR
Al-Azhar University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al-Azhar university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-OP-23-03
Identifier Type: -
Identifier Source: org_study_id